ARTICLE | Clinical News
Abraxane nab-paclitaxel regulatory update
October 4, 2010 7:00 AM UTC
The COMP issued a positive opinion to grant Orphan Drug designation for Abraxis' Abraxane nab-paclitaxel to treat pancreatic cancer. The albumin stabilized nanoparticle formulation of paclitaxel is i...